Versartis, Inc. 4
4 · Versartis, Inc. · Filed Apr 5, 2017
Insider Transaction Report
Form 4
Versartis, Inc.VSAR
Hislop Colin
Chief Medical Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2017-04-04−35,000→ 188,100 totalExercise: $8.17Exp: 2026-04-03→ Common Stock (35,000 underlying) - Exercise/Conversion
Common Stock
2017-04-04$8.17/sh+35,000$285,950→ 59,500 total - Sale
Common Stock
2017-04-04$21.20/sh−35,000$742,000→ 24,500 total
Footnotes (3)
- [F1]Shares sold pursuant to a 10b5-1 plan.
- [F2]The shares were sold at prices ranging from $20.90 to $21.65. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]1/4th of the total number of shares subject to the option shall vest on the first yearly anniversary of the vesting commencement date and 1/36th of the remaining number of shares subject to the option shall vest on each monthly anniversary of the vesting commencement date thereafter.